Team
Leaders redrawing the bounds of treatment.
Board Of Directors & Management
Team
Leaders redrawing the bounds of treatment.
BOARD OF
DIRECTORS & MANAGEMENT
World-class Scientific Advisory Board
Based in Madison, WI
ENDSULIN is developing a revolutionary genetic therapy for T1DM that with a single administration would restore the body’s own ability to produce and regulate insulin. Our goal is to deliver a patented genetic factor that will “switch on” new insulin-producing cells to confer years – and perhaps a lifetime – of freedom from injecting artificial insulin, realizing the goal that has eluded researchers since the discovery of insulin.
